Why Patients and Doctors Love DSLT

item

Drop-free Alternative

Solve patient compliance

item

Efficient

As Convenient as Prescribing Eye Drops

item

Ease of Use

Intuitive Set Up and Functionality

item

Treat More Patients

Expanded Revenue Stream

quote

Physician
Experiences

Clinically Proven

Our pivotal RCT demonstrates equivalence to SLT. A practice-changing
technology allowing you to treat your patients efficiently and effectively.

item

Proof of Concept

Status: Completed 2014

Number of Patients: 28

Primary Endpoint: IOP reduction at 6 months

Read more
item

First-in-Human

Status: Completed 2019

Number of Patients: 15

Primary Endpoint: IOP reduction at 3 months

Read more
item

GLAUrious – Multicenter Randomized
Controlled Study

Status: Enrollment Complete

Number of Patients: 192

Primary Endpoint: IOP reduction at 6 months

Read more
icon

Find a Distributor

Learn More

Product
Brochure

Download our brochure to
learn more.

BELKIN Vision Publications

2022 Journal of Glaucoma

Energy Dose-Response in Selective Laser Trabeculoplasty:
A Review

Radcliffe N, et al.

Read More

2021 TVST – ARVO Journal

Automated Direct Selective Laser Trabeculoplasty: First Prospective Clinical Trial

Goldenfeld M, et al.

Read More

2020 Biomedial Optics Express

Non-contact direct selective laser trabeculoplasty: light propagation analysis

Sacks Z, et al.

Read More

Get our latest news and updates!

Subscribe to receive BELKIN Vision's Newsletter with the latest news and clinical updates.

Skip to content